Kalaris Therapeutics, Inc (KLRS) insider trading
Every open-market stock purchase and sale by Kalaris Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $6.2M over the last 12 months (2 buys).
- Insiders sold $12.9K over the last 12 months (1 sale).
- Last insider buy: Srinivas Akkaraju (Insider), $1.2M, 4 months ago.
Last 12 months: insiders bought $6.2M (2 buys) and sold $12.9K (1 sale). Last close $4.44 on Jun 4, 2026.
Recent KLRS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | Morana Jovan-Embiricos (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Anthony P Adamis (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Michael Dybbs (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Napoleone Ferrara (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | David Hallal (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Leone D Patterson (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Srinivas Akkaraju (Insider) | Bought (not open market) | — |
| May 20, 2026 | Srinivas Akkaraju (Insider) | Bought | $1.2M |
| May 20, 2026 | Srinivas Akkaraju (Insider) | Sold (not open market) | — |
| May 20, 2026 | Srinivas Akkaraju (Insider) | Bought (not open market) | — |
| May 20, 2026 | Srinivas Akkaraju (Insider) | Bought (not open market) | — |
| Mar 20, 2026 | Brett R Hagen (C-suite exec) | Sold | $12.9K |
| Mar 19, 2026 | Andrew Oxtoby (Insider) | Bought (not open market) | — |
| Mar 19, 2026 | Brett R Hagen (C-suite exec) | Bought (not open market) | — |
| Mar 19, 2026 | Matthew Gall (CFO) | Bought (not open market) | — |
| Mar 19, 2026 | Matthew Feinsod (C-suite exec) | Bought (not open market) | — |
| Dec 22, 2025 | Srinivas Akkaraju (Insider) | Bought (not open market) | $15M |
| Dec 18, 2025 | Srinivas Akkaraju (Insider) | Bought | $5M |
| Nov 3, 2025 | Matthew Gall (CFO) | Bought (not open market) | — |
Who's trading KLRS
- Anthony P Adamis, Insider: other filings, last Jun 3, 2026
- Srinivas Akkaraju, Insider: bought $6.2M (2 buys), last Jun 3, 2026
- Michael Dybbs, Insider: other filings, last Jun 3, 2026
- Napoleone Ferrara, Insider: other filings, last Jun 3, 2026
- David Hallal, Insider: other filings, last Jun 3, 2026
- Morana Jovan-Embiricos, Insider: other filings, last Jun 3, 2026
- Leone D Patterson, Insider: other filings, last Jun 3, 2026
- Brett R Hagen, C-suite exec: sold $12.9K (1 sale), last Mar 20, 2026
- Andrew Oxtoby, Insider: other filings, last Mar 19, 2026
- Matthew Feinsod, C-suite exec: other filings, last Mar 19, 2026
- Matthew Gall, CFO: other filings, last Mar 19, 2026
Get free alerts when an insider at Kalaris Therapeutics, Inc files a new trade →